Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone versus ondansetron for prevention of post-dural puncture headache after cesarean section
PACTR202503701455932Phase 0Not yet recruiting
- Sponsor
- Dr Okeke Nnaemeka Benedict
- Start
- Mar 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 0 trial of dexamethasone and ondansetron in post-dural puncture headache (PDPH) (3 arms), sponsored by Dr Okeke Nnaemeka Benedict. Primary endpoints: Occurrence of post-dural puncture headache and Severity of post-dural puncture headache. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
dexamethasoneondansetron
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on PACTR202503701455932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202503701455932.